The Claim

Among adults treated with rosuvastatin, attainment of LDL cholesterol below 50 mg/dL is associated with a 46% reduction in all-cause mortality compared to those who do not reach this level.

Source: Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Adults taking rosuvastatin who lower their LDL cholesterol to below 50 mg/dL have a 46% lower rate of death from any cause compared to those whose LDL cholesterol remains above this level.

See the scientific wording

Among adults treated with rosuvastatin, attainment of LDL cholesterol below 50 mg/dL is associated with a 46% reduction in all-cause mortality compared to those who do not reach this level, suggesting a potential survival benefit from more intensive lipid-lowering.

Why this might work

Rosuvastatin blocks cholesterol production in the liver, causing liver cells to pull more bad cholesterol out of the blood. Lower cholesterol in the blood means less buildup in artery walls, which stops plaques from growing and bursting. This prevents heart attacks, strokes, and other deadly blockages that cause death.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

    People taking rosuvastatin who got their bad cholesterol below 50 mg/dL were nearly half as likely to die from any cause during the study compared to those whose cholesterol stayed above 50 mg/dL — and they didn’t have more side effects.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.